Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Janssen unblinds Phase III TITAN study for prostate cancer

TITAN trial aims to Erleadain combination with androgen deprivation therapy in patients with mCSPC. Credit: Photo by Paweł Czerwiński on Unsplash.



  • Janssen

Go Top